HCLTech bets on AI to turn pilots into biz gains
HCLTech is leveraging artificial intelligence (AI) tailored to specific industries and business functions to encourage wider adoption of the technology. The company unveiled a collection of 20 Industry AI Solutions encompassing sectors such as banking, healthcare, aerospace, retail, telecom, mobility, energy, and manufacturing on October 8. While many of these tools are already deployed at scale for clients worldwide, others are in the early stages of deployment.
Gaurav Dhakar, the global head of Industry AI Solutions at HCLTech, emphasized that AI has the potential to revolutionize business value chains but requires deep domain specificity and scalability to realize that potential. To achieve this, HCLTech is developing tools based on the requirements of particular industries and business functions. The company built its portfolio in-house with the assistance of a global team of engineers and domain experts as part of its strategy to build its own AI intellectual property.
Several prominent clients are already benefiting from HCLTech's Industry AI solutions. For instance, a global manufacturer of motorbikes and tools has employed HCLTech's Autonomous Accounts Payable platform to streamline invoice processing. This AI tool has reportedly reduced invoice processing time by 60%. In manufacturing and logistics, HCLTech's VisionX platform has demonstrated significant improvements.
The computer vision-based system has enhanced response times by over 90% and decreased operating costs by more than 70% across factories and warehouses.
HCLTech's SmartTwin system, on the other hand, empowers manufacturers to simulate products and plants before actual deployment. This AI-driven simulation is said to have shortened the go-to-market time by 44%, broadening the portfolio's scope beyond day-to-day operations to include product development. In the healthcare and life sciences domain, HCLTech is addressing regulatory work and drug safety reporting.
The Intelligent Regulatory Platform supplies regulatory intelligence, while the Intelligent Safety Platform has cut pharmacovigilance case-processing time by 40-50%, according to the company. Pharmacovigilance pertains to the monitoring and evaluation of potential adverse effects of medications.
Rewritten by urgent.news; may contain errors — check the original.
Source: economictimes.indiatimes.com